FOXD2-AS1 Gene

Name FOXD2 antisense RNA 1 (head to head)
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n FOXD2‐AS1 is a long noncoding RNA that is aberrantly upregulated in a wide variety of human cancers and other pathologic conditions, and its dysregulation is strongly correlated with aggressive clinical features and poor patient prognosis (38,41). In multiple solid tumors—including gastric, colorectal, bladder, non‐small cell lung, hepatocellular, breast, nasopharyngeal, esophageal, glioma, cholangiocarcinoma, gallbladder, cervical, tongue squamous cell, pancreatic, and cutaneous melanoma cancers—FOXD2‐AS1 exerts an oncogenic function by promoting cell proliferation, migration, invasion, epithelial–mesenchymal transition (EMT), and stemness, as well as by fostering chemoresistance (1–6, 8, 10–14, 16, 17, 19, 22, 27, 29, 31, 36, 39, 40).\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Mechanistically, FOXD2‐AS1 predominantly functions as a competing endogenous RNA, sequestering multiple microRNAs (such as miR‑206, miR‑185‐5p, miR‑143, miR‑31, miR‑27a‑3p, miR‑150‑5p, miR‑98‑5p, miR‑760, miR‑30a‑3p, and miR‑331‑3p) to indirectly upregulate target oncogenes including EphB3, cell division regulators (e.g. CCND2 and CDK1), ABCC3, PFN2, MAP3K1, COX‑2, and E2F3 (1, 3–5, 11, 12, 14, 16, 17, 23, 27, 29, 31, 37, 39). In addition, FOXD2‐AS1 interacts with key epigenetic regulators such as EZH2 and LSD1 and with DNA methylation or transcription factors (for example, CREB1, TAF‑1, and DNMT1) to repress tumor suppressor genes including DKK1, p21, CDKN1B, MLH1, and CDX1 (4, 15, 20, 21, 32, 33). Consequently, activation of several signaling pathways—including Wnt/β‑catenin, PI3K/AKT, Hippo/YAP, Notch, NF‑κB, and ERK/MAPK—has been observed upon FOXD2‑AS1 upregulation, thereby further enhancing tumor progression (6, 9, 16, 17, 19, 24, 27, 31, 34, 36).\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond cancer, increased FOXD2‐AS1 levels have been implicated in non‐malignant diseases such as osteoarthritis and rheumatoid arthritis. In osteoarthritis, FOXD2‐AS1 promotes chondrocyte viability, inflammation, and extracellular matrix degradation through modulation of the miR‑206/Cyclin D1 axis and the miR‑27a‑3p/TLR4 pathway (7, 9), while in rheumatoid arthritis it enhances fibroblast‑like synoviocyte proliferation and invasion via a miR‑331‑3p/PIAS3 regulatory mechanism (26).\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, the studies indicate that FOXD2‑AS1 is a multifaceted oncogenic lncRNA whose upregulation not only drives tumorigenesis and progression via diverse molecular mechanisms but also represents a promising prognostic biomarker and potential therapeutic target across various cancers.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n <!-- Hyperlinked citations -->\n <small>\n (1)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", \n (2)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", \n (3)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", \n (4)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", \n (5)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", \n (6)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", \n (7)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", \n (8)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", \n (9)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", \n (10)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", \n (11)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": ", \n (12)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", \n (13)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": ", \n (14)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", \n (15)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", \n (16)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ", \n (17)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", \n (19)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": ", \n (20)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", \n (21)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ", \n (22)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": ", \n (23)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ", \n (24)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": ", \n (25)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": ", \n (26)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": ", \n (27)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": ", \n (28)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": ", \n (29)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": ", \n (30)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": ", \n (31)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": ", \n (32)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": ", \n (33)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": ", \n (34)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": ", \n (35)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "34"}]}, {"type": "t", "text": ", \n (36)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "35"}]}, {"type": "t", "text": ", \n (37)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "36"}]}, {"type": "t", "text": ", \n (38)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": ", \n (39)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "38"}]}, {"type": "t", "text": ", \n (40)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "39"}]}, {"type": "t", "text": ", \n (41)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "40"}]}, {"type": "t", "text": "</small>\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tong-Peng Xu, Wen-Yu Wang, Pei Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0308-y"}], "href": "https://doi.org/10.1038/s41388-018-0308-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29789713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29789713"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "X Yang, B Duan, X Zhou "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2017)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28925486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28925486"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Qing An, Liyang Zhou, Nan Xu "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.03.138"}], "href": "https://doi.org/10.1016/j.biopha.2018.03.138"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29674277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29674277"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Feng Su, Wang He, Changhao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0275-9"}], "href": "https://doi.org/10.1038/s41419-018-0275-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29445134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29445134"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yanyan Zhu, Liang Qiao, Yun Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FOXD2-AS1 contributes to colorectal cancer proliferation through its interaction with microRNA-185-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13632"}], "href": "https://doi.org/10.1111/cas.13632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29737580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29737580"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lin Rong, Ruixing Zhao, Jinxiu Lu "}, {"type": "b", "children": [{"type": "t", "text": "Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.01.141"}], "href": "https://doi.org/10.1016/j.bbrc.2017.01.141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28132805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28132805"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lei Cao, Yang Wang, Qiugen Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.07.048"}], "href": "https://doi.org/10.1016/j.biopha.2018.07.048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30119190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30119190"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Gang Chen, Wenjie Sun, Xinying Hua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.12.026"}], "href": "https://doi.org/10.1016/j.gene.2017.12.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29248577"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29248577"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yang Wang, Lei Cao, Qiugen Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Artif Cells Nanomed Biotechnol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21691401.2019.1596940"}], "href": "https://doi.org/10.1080/21691401.2019.1596940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30945573"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30945573"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jie Bao, Chenjie Zhou, Jiaqing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-170260"}], "href": "https://doi.org/10.3233/CBM-170260"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29286915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29286915"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Fazheng Shen, Haigang Chang, Guojun Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28208"}], "href": "https://doi.org/10.1002/jcb.28208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30520141"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30520141"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Huixiao Dong, Wei Cao, Jian Xue "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.12.050"}], "href": "https://doi.org/10.1016/j.bbrc.2018.12.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30553445"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30553445"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Rui Li, Shuwei Chen, Jiandong Zhan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2232-7"}], "href": "https://doi.org/10.1038/s41419-020-2232-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31959918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31959918"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Naibing Gu, Xinlai Wang, Zhengli Di, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102455"}], "href": "https://doi.org/10.18632/aging.102455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31770107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31770107"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yuanhong Chang, Jie Zhang, Cancan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR‑206."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2018.6752"}], "href": "https://doi.org/10.3892/or.2018.6752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30272362"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30272362"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jin Wang, Bingqiang Li, Cunzu Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29284"}], "href": "https://doi.org/10.1002/jcb.29284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31347720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31347720"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ming Jiang, Ni Qiu, Haoming Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2019.4671"}], "href": "https://doi.org/10.3892/ijo.2019.4671"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30628646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30628646"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ting Lei, Xiaodong Zhu, Kai Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2019.1595276"}], "href": "https://doi.org/10.1080/15384047.2019.1595276"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30929558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30929558"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Zhipeng Ren, Yongcheng Hu, Guishi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109104"}], "href": "https://doi.org/10.1016/j.biopha.2019.109104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31228799"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31228799"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Kangdi Xu, Zhihao Zhang, Junjie Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B(p27) via EZH2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2019.04.016"}], "href": "https://doi.org/10.1016/j.yexcr.2019.04.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31004581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31004581"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Wenqing Ren, Zirong Zhu, Lina Wu "}, {"type": "b", "children": [{"type": "t", "text": "FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27820"}], "href": "https://doi.org/10.1002/jcb.27820"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30426532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30426532"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Wei Hu, Hui Feng, Xiaoyu Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.3204"}], "href": "https://doi.org/10.1002/cam4.3204"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32558350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32558350"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Zheng Chen, Zhen Zhang, Dongbo Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.918230"}], "href": "https://doi.org/10.12659/MSM.918230"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31841454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31841454"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Q-Q Zhang, S-L Xu, C Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202101_24629"}], "href": "https://doi.org/10.26355/eurrev_202101_24629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33577022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33577022"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Qirui Zhao, Fengnian Zhao, Chang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autoimmunity (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/08916934.2021.1919879"}], "href": "https://doi.org/10.1080/08916934.2021.1919879"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34030529"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34030529"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yang Wang, Yanli Cheng, Qi Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.17268"}], "href": "https://doi.org/10.1111/jcmm.17268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35419917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35419917"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Zheqi Liu, Wenkai Zhou, Chengzhong Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.202268"}], "href": "https://doi.org/10.18632/aging.202268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33318296"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33318296"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Zengtao Hu, Lining Huang, Weina Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dig Dis Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10620-021-06876-9"}], "href": "https://doi.org/10.1007/s10620-021-06876-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33570683"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33570683"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Q-S Zhao, J-B Ying, J-J Jing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202004_21019"}], "href": "https://doi.org/10.26355/eurrev_202004_21019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32373975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32373975"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Pei Huang, Jinhui Xue "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2020.4699"}], "href": "https://doi.org/10.3892/ijmm.2020.4699"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32945354"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32945354"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jun Gao, Chao Dai, Xin Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41434-020-00187-w"}], "href": "https://doi.org/10.1038/s41434-020-00187-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32917950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32917950"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "D-Z Chen, T-F Wang, W-C Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FOXD2-AS1 accelerates the progression of cervical cancer via downregulating CDX1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201912_19660"}], "href": "https://doi.org/10.26355/eurrev_201912_19660"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31841177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31841177"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Ali Rajabi, Sepideh Bastani, Melika Maydanchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastrointest Cancer (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12029-021-00686-y"}], "href": "https://doi.org/10.1007/s12029-021-00686-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34478035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34478035"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Haomeng Zhang, Yao Lu, Jun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2019.10254"}], "href": "https://doi.org/10.3892/mmr.2019.10254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31115575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31115575"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Guangming Zhou, Zixian Huang, Yiyi Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oral Pathol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jop.13074"}], "href": "https://doi.org/10.1111/jop.13074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32531865"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32531865"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Yali Gao, Xiaoling Luo, Jun Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Activation of LncRNA FOXD2-AS1 by H3K27 acetylation regulates VEGF-A expression by sponging miR-205-5p in recurrent pterygium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.16024"}], "href": "https://doi.org/10.1111/jcmm.16024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33098266"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33098266"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Lu Zhou, Zhi Li, Xinye Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2019.152449"}], "href": "https://doi.org/10.1016/j.prp.2019.152449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31378453"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31378453"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Zhihua Ye, Yingyu Yang, Ying Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Noncoding RNA FOXD2-AS1 Promotes Pancreas Adenocarcinoma Cell Invasion and Migration by Sponging miR-30a-3p to Upregulate COX-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Eukaryot Gene Expr (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1615/CritRevEukaryotGeneExpr.2021039235"}], "href": "https://doi.org/10.1615/CritRevEukaryotGeneExpr.2021039235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35377978"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35377978"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Xiaowei Liang, Zhizhao Chen, Geng Wu "}, {"type": "b", "children": [{"type": "t", "text": "FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Transplant (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0963689720964411"}], "href": "https://doi.org/10.1177/0963689720964411"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33103475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33103475"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Yongping Zhang, Chaojie Liang, Yu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20190372"}], "href": "https://doi.org/10.1042/BSR20190372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33140822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33140822"}]}]}]}
NCBI Gene ID 84793
API
Download Associations
Predicted Functions View FOXD2-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View FOXD2-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FOXD2-AS1's ARCHS4 Predicted Functions.

Functional Associations

FOXD2-AS1 has 831 functional associations with biological entities spanning 4 categories (organism, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 14 datasets.

Click the + buttons to view associations for FOXD2-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of FOXD2-AS1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FOXD2-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with FOXD2-AS1 gene from the CellMarker Gene-Cell Type Associations dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FOXD2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of FOXD2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of FOXD2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of FOXD2-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FOXD2-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FOXD2-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of FOXD2-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FOXD2-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of FOXD2-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of FOXD2-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of FOXD2-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.